Article Details
Retrieved on: 2018-11-15 02:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Crosslink Capital</b> Inc decreased its stake in Cyrusone (CONE) by 47.73% based on its latest 2018Q2 regulatory filing with the SEC. <b>Crosslink Capital</b> ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here